Safety, Tolerability and Pharmacokinetics of AD16 Tablets After MAD in Healthy Chinese Adult Subjects
Clinical trial NCT05806177 · COMPLETED
Trial details
- NCT number
- NCT05806177
- Sponsor
- South China Center For Innovative Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-26
- Primary completion
- 2020-07-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.